| Bulk Drugs | Active pharmaceutical ingredients for therapeutics like anti-malarials and anti-inflammatory drugs. | WHO certifications, specialized anti-malarial APIs, and in-house raw material manufacturing provide competitive edge. | Pharmaceutical companies within India and international markets (B2B). | Specialty anti-malarial APIs like Lumefantrine and Sulfadoxine exhibit higher margins. | 108 | 34 | Sales of APIs to pharmaceutical manufacturers under B2B contracts. | Contract pricing with customers, long term supply agreements. | API innovations, WHO approvals, global health collaborations boosting anti-malarial API demand. | |
| Chemicals & Others | Manufacture of disperse dye intermediates, perfumery chemicals, and inorganic chemicals. | Established manufacturing facilities and chemical expertise. | Chemical manufacturers and industries requiring intermediates (B2B). | Specialty and perfumery chemicals have better profitability. | 4 | 1 | Sale of chemical intermediates primarily to chemical and allied industries. | Direct sales and contract manufacturing. | Industrial chemical demand and diversification into specialty chemicals. | |
